Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

725
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
725
Introduction to Epidemiology01:26

Introduction to Epidemiology

816
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
816
Prevalence and Incidence01:08

Prevalence and Incidence

652
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
652
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

3.7K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.7K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

169
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
169
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

1.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir.

Signal transduction and targeted therapy·2026
Same author

Convergent evolution of the N156K mutation in A(H1N1)pdm09 hemagglutinin contributes to antigenic drift and cluster transition.

Emerging microbes & infections·2026
Same author

Algorithm-Optimized H5 Influenza mRNA Vaccine Induces Broad Immune Responses.

International journal of molecular sciences·2026
Same author

Pan-filovirus activity of an IGF2-fused monoclonal antibody: Impairment by IGF1R cross-engagement and rescue via IGF2 Y27L mutation.

Virus research·2026
Same author

Preclinical evaluation of an mRNA vaccine developed from the first human isolate of bovine H5N1.

Cell reports. Medicine·2026
Same author

Fascin-1 Limits Secondary Damage by Preventing Oxidative‑Stress‑Induced Microglial Death After Spinal Cord Injury.

Neurochemical research·2026

Related Experiment Video

Updated: Jul 29, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K

Epidemiology of Hepatitis E.

Yansheng Geng1, Tengfei Shi1, Youchun Wang2

  • 1Key Laboratory of Public Health Safety of Hebei Province, School of Public Health, Hebei University, Baoding, China.

Advances in Experimental Medicine and Biology
|May 24, 2023
PubMed
Summary
This summary is machine-generated.

Hepatitis E virus (HEV) causes widespread liver infections globally. Different HEV genotypes lead to distinct transmission patterns and affect different populations, with a vaccine available in China.

Keywords:
Anti-HEV IgGGenotypeHepatitis E virusOutbreakPrevalenceReservoir

More Related Videos

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.5K
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

7.0K

Related Experiment Videos

Last Updated: Jul 29, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.5K
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

7.0K

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Hepatitis E virus (HEV) infection is a global health concern with high seroprevalence.
  • Two epidemiological patterns exist: genotype 1/2 in developing countries (waterborne, affecting young adults and pregnant women) and genotype 3/4 in developed countries (zoonotic, affecting the elderly).
  • Persistent HEV infections are noted in immunosuppressed individuals.

Purpose of the Study:

  • To provide an overview of the global prevalence and epidemiological patterns of Hepatitis E virus.
  • To differentiate between HEV genotypes, their transmission routes, and affected demographics.
  • To highlight the severity in specific populations and the availability of preventative measures.

Main Methods:

  • Review of epidemiological data on Hepatitis E virus.
  • Analysis of HEV genotypes and their geographical distribution.
  • Summary of transmission routes, clinical manifestations, and risk factors.

Main Results:

  • HEV is prevalent worldwide, with distinct genotype-specific epidemiology.
  • Waterborne transmission (HEV-1, HEV-2) causes outbreaks in developing nations, severe in pregnant women.
  • Zoonotic transmission (HEV-3, HEV-4) occurs in developed countries, with persistent infections in the immunocompromised.

Conclusions:

  • Hepatitis E presents diverse epidemiological profiles globally.
  • Understanding HEV genotypes is crucial for targeted prevention and control strategies.
  • A subunit vaccine has demonstrated efficacy and is licensed in China.